Collegium Pharmaceutical, Inc. (COLL)
22.02
+0.18
(+0.82%)
USD |
NASDAQ |
Oct 02, 16:00
22.05
+0.03
(+0.14%)
After-Hours: 20:00
Collegium Pharmaceutical Max Drawdown (5Y) : 56.22% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 56.22% |
| August 31, 2026 | 51.32% |
| July 31, 2026 | 51.32% |
| June 30, 2026 | 51.32% |
| May 31, 2026 | 51.32% |
| April 30, 2026 | 51.32% |
| March 31, 2026 | 51.32% |
| February 28, 2026 | 51.32% |
| January 31, 2026 | 51.32% |
| December 31, 2025 | 51.32% |
| November 30, 2025 | 51.32% |
| October 31, 2025 | 51.32% |
| September 30, 2025 | 51.32% |
| August 31, 2025 | 51.32% |
| July 31, 2025 | 51.32% |
| June 30, 2025 | 51.32% |
| May 31, 2025 | 51.32% |
| April 30, 2025 | 51.32% |
| March 31, 2025 | 51.32% |
| February 28, 2025 | 52.45% |
| January 31, 2025 | 52.45% |
| December 31, 2024 | 52.45% |
| November 30, 2024 | 52.45% |
| October 31, 2024 | 54.13% |
| September 30, 2024 | 61.97% |
| Date | Value |
|---|---|
| August 31, 2024 | 63.88% |
| July 31, 2024 | 64.05% |
| June 30, 2024 | 65.22% |
| May 31, 2024 | 65.22% |
| April 30, 2024 | 65.22% |
| March 31, 2024 | 65.22% |
| February 29, 2024 | 65.22% |
| January 31, 2024 | 65.22% |
| December 31, 2023 | 65.22% |
| November 30, 2023 | 65.22% |
| October 31, 2023 | 65.22% |
| September 30, 2023 | 65.22% |
| August 31, 2023 | 65.22% |
| July 31, 2023 | 65.22% |
| June 30, 2023 | 65.22% |
| May 31, 2023 | 65.22% |
| April 30, 2023 | 65.22% |
| March 31, 2023 | 65.22% |
| February 28, 2023 | 65.22% |
| January 31, 2023 | 65.22% |
| December 31, 2022 | 65.22% |
| November 30, 2022 | 65.22% |
| October 31, 2022 | 67.64% |
| September 30, 2022 | 67.64% |
| August 31, 2022 | 67.64% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Innoviva, Inc. | 47.01% |
| Zevra Therapeutics, Inc. | 96.86% |
| ANI Pharmaceuticals, Inc. | 72.96% |
| Corcept Therapeutics, Inc. | 71.85% |
| Veru, Inc. | 99.12% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -9.094 |
| Beta (5Y) | 0.7329 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 41.27% |
| Historical Sharpe Ratio (5Y) | -0.0427 |
| Historical Sortino (5Y) | -0.0753 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 19.48% |